Introduction
============

Cardiovascular Magnetic Resonance (CMR) allows an accurate and reproducible quantification of left ventricular (LV) parameters. In Thalassemia major (TM) patients have been reported different "normal" LV values due to chronic anemia and eventually pre-existing iron burdens. Moreover, in this population it is unknown the influence of sex and age on LV parameters and no ranges of normal have been reported using MASS® software. The aim of this study was to establish the ranges for normal LV volumes, mass and ejection fraction normalized to the influence of body surface area(BSA), age and sex from CMR in a large cohort of well-treated TM patients without myocardial iron overload.

Materials
=========

Among the 923 TM patients who underwent CMR within the MIOT network for the assessment of cardiac iron overload, function and fibrosis, we selected 142 patients with no known risk factors or history of cardiac disease, normal electrocardiogram, no myocardial fibrosis and no myocardial iron overload (all the cardiac segments with a normal T2\* value). All patients had been regularly transfused and chelated since early childhood. Moreover, we studied 71 healthy subjects matched for age and sex. LV function parameters were quantitatively evaluated in a standard way by SSFP cine images using MASS® software. LV end-diastolic volume, end-systolic volume, stroke volume, and mass were normalized to BSA (EDVI, ESVI, SVI, massI).

Results
=======

Table [1](#T1){ref-type="table"} shows the comparison of the CMR parameters with differentiation for sex and age in TM patients and healthy subjects and the cut-off of normality defined as mean - 2 standard deviation (SD). TM patients showed significantly lower BSA than the controls (P\<0.0001). Significantly higher EDVI and SVI were found only for males 30 years. Significantly higher LVEF were found only for males \< 14 years. In TM patients all LV volumes indexes were significantly larger in males than in females (P\<0.0001 in all cases). The EF was not different between the sexes. In males the ESVI and the EF were significant different among the age groups (P=0.006 and P=0.001, respectively). In females no significant differences were detected among the age groups.

                    \< 14          14-20     20-30      30-40          \>=40                                                                                                          
  ----------------- -------------- --------- ---------- -------------- --------- ------- --------------- ---------- ------- -------------- --------- ------- -------------- --------- -------
                    **TM**         **H**     **P**      **TM**         **H**     **P**   **TM**          **H**      **P**   **TM**         **H**     **P**   **TM**         **H**     **P**
                                                                                                                                                                                      
  **Males**         *N=7*          *N=7*                *N=6*          *N=6*             *N=25*          *N1=15*            *N=23*         *N=11*            *N=6*          *N=5*     
                                                                                                                                                                                      
  EDVI (ml/m^2^)    94 ± 18 (58)   75 ± 11   0.034      96 ± 20 (56)   91 ± 20   0.715   103 ± 17 (69)   101 ± 13   0.686   92 ± 15 (62)   80 ± 11   0.222   94 ± 9 (76)    75 ± 11   0.013
  ESVI (ml/m2)      31 ± 6 (19)    24 ± 6    0.058      36 ± 8 (22)    35 ± 14   0.760   38 ± 8 (22)     39 ± 9     0.676   32 ± 6 (20)    29 ± 6    0.160   29 ± 6 (17)    28 ± 10   0.816
  SVI (ml/m^2^)     63 ± 14 (35)   51 ± 7    0.05       57 ± 12 (33)   56 ± 8    0.868   65 ± 10 (45)    62 ± 9     0.433   59 ± 10 (39)   51 ± 10   0.027   64 ± 8 (48)    47 ± 8    0.007
  Mass I (g/m^2^)   57 ± 7 (43)    68 ± 5    0.007      57 ± 13 (31)   71 ± 7    0.043   66 ± 12 (42)    77 ± 12    0.006   62 ± 12 (38)   66 ± 10   0.184   69 ± 16 (36)   74 ± 11   0.536
  EF (%)            66 ± 4 (58)    54 ± 6    \<0.0001   60 ± 2 (56)    66 ± 14   0.322   63 ± 3 (57)     62 ± 6     0.520   65 ± 3 (59)    65 ± 8    0.972   68 ± 6 (56)    62 ± 9    0.234
                                                                                                                                                                                      
  **Females**       *N=2*          *N=2*                *N=8*          *N=6*             *N=24*          *N=6*              *N=33*         *N=8*             *N=8*          *N=5*     
                                                                                                                                                                                      
  EDVI (ml/m^2^)    53 ± 8 (47)    62 ± 4    0.951      81 ± 8 (65)    80 ± 9    0.866   83 ± 16 (51)    78 ± 9     0.499   77 ± 11 (55)   79 ± 10   0.669   82 ± 19 (44)   77 ± 16   0.614
  ESVI (ml/m2)      23 ± 1 (21)    22 ±8     0.823      30 ± 6 (18)    31 ± 3    0.789   30 ± 8 (14)     30 ± 4     0.883   26 ± 6 (14)    29 ± 7    0.216   26 ± 8 (12)    28 ± 12   0.974
  SVI (ml/m^2^)     40 ± 7 (26)    41 ± 4    0.919      49 ± 3 (43)    49 ± 6    0.892   53 ± 9 (35)     48 ± 6     0.234   51 ± 6 (39)    50 ± 8    0.915   54 ±11 (32)    49 ± 6    0.394
  Mass I (g/m^2^)   34 ± 3 (28)    59 ± 19   0.296      47 ± 8 (31)    56 ± 6    0.040   53 ± 9 (35)     54 ± 12    0.893   52 ± 9 (34)    55 ± 13   0.465   51 ± 12 (27)   56 ± 5    0.344
  EF (%)            62 ± 3 (57)    46 ± 17   0.388      63 ± 4 (55)    62 ± 4    0.694   65 ± 5 (55)     62 ± 3     0.137   66 ± 5 (56)    63 ± 7    0.271   66 ± 4 (58)    63 ± 7    0.254

Conclusion
==========

In a large cohort of well-treated TM patients significant differences in LV parameters compared to controls were limited to males \< 14 years and \> 30 years. Appropriate "normal" reference ranges normalized to BSA, sex and age should be used to avoid misdiagnosis of cardiomiopathy in TM patients.
